Publication details
Cetuximab v záchovném protokolu lokoregionálně pokročilých karcinomů hlavy a krku: první klinické zkušenosti a možnosti výzkumu v oblasti predikce účinnosti léčby
| Title in English | Cetuximab in organ preservation protocol of locoregionally advanced head and neck cancers |
|---|---|
| Authors | |
| Year of publication | 2008 |
| Type | Article in Periodical |
| Magazine / Source | Otorinolaryngologie a foniatrie |
| MU Faculty or unit | |
| Citation | |
| Field | ORL, ophthalmology, stomatology |
| Keywords | head and neck cancers targeted therapy EGFR inhibitor cetuximab EGFR mutation predictive marker arker |
| Description | The integration of EGFR inhibitors to the treatment of head and neck cancers means considerable advancement in oncology. Extracellular inhibitors show effectiveness in the treatment of head and neck cancers. The research of predictive markers is being carried out together with the EGFR inhibitors treatment. |